Newmont Publishes 2020 Sustainability Report
3.6.2021 14:30:00 EEST | Business Wire | Press release
Today, Newmont Corporation (NYSE: NEM, TSX: NGT) launched its 2020 Annual Sustainability Report, part of the suite of reports on the Company’s environmental, social and governance (ESG) practices in key areas that include health, safety and security, human rights, the environment, social acceptance, governance, and inclusion and diversity.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210603005281/en/
Newmont Corporation's 2020 Annual Sustainability Report, the 17th successive report outlining the Company's commitment to sustainable and responsible mining and leading ESG practices. (Graphic: Business Wire)
“As we celebrate our 100th year, Newmont’s commitment to sustainable and responsible mining has never been stronger. Our sustainability report provides a comprehensive review of our safety, environmental and social performance,” said Newmont’s President and CEO Tom Palmer. “With this report we offer a transparent review of how we work toward making a positive difference in the lives of our employees, stakeholders, business partners and host communities around the world.”
Highlights of Newmont’s 2020 Sustainability Report:
-
Commitment to health and safety: Achieved the best safety and financial performance in the Company’s history. Investments in our Fatality Risk Management program and a focus on the critical controls that prevent fatalities resulted in Newmont reducing potentially significant events and achieving the lowest injury rate in its history.
-
Response to COVID-19: Activated the Company’s Rapid Response program to preserve the health and safety of the workforce, host and nearby Indigenous communities during the COVID-19 pandemic. Through Newmont’s COVID-19 Global Community Support Fund, the Company has supported communities’ management and recovery from the pandemic in three key areas of need: workforce and community health, food security, and local economic resilience.
-
Addressing climate change: Furthered Newmont’s commitment to environmental stewardship by announcing industry-leading climate change targets of more than a 30 percent reduction in Scope 1 and 2 emissions and a 30 percent reduction in Scope 3 missions by 2030, with an ultimate aspiration of being net zero carbon by 2050. Newmont has committed $500 million over the next five years to support efforts to meeting these goals.
- Continued value sharing: Newmont continued to play an important role in creating economic value in host communities and jurisdictions, contributing $7.7 billion in economic value for its workforce, host communities and jurisdictions through wages and benefits, operating costs, capital spend, royalties, and taxes. This also includes spending $3.9 billion with local and national suppliers and investing $20.5 million in community projects and providing ongoing opportunities for local and Indigenous employment.
Newmont’s sustainability efforts continue to be recognized by several leading independent organizations:
- Recognized as top-ranked gold miner for the sixth consecutive year in the Dow Jones Sustainability Index (DJSI) while continuing to be recognized as the top mining company on FORTUNE’s list of the World’s Most Admired Companies;
- Earned a score of “A-“ from CDP for the CDP Climate assessment, reflecting the coordinated action on climate issues;
- Listed as 6th overall and the top mining company in 3BL’s 100 Best Corporate Citizens;
- Achieved a perfect score of 100 on the Human Rights Campaign Foundation’s Corporate Equity Index for the Company’s work in creating an inclusive workplace for LGBTQ+ employees, and was included in Bloomberg’s Gender-Equality Index (GEI) for Newmont’s efforts to advance women in the workplace; and
- Ranked as the top gold miner in Newsweek’s list of America’s Most Responsible Companies for 2020 and as the second most transparent company in the S&P 500.
Newmont’s 2020 Sustainability Report is written in accordance with the GRI Standards Core option, the GRI Mining and Metals Sector Supplement, the Sustainability Accounting Standards Board (SASB) Metals and Mining protocol, and is externally assured. Additionally, this report aligns with two new disclosure frameworks, ICMM’s Mining Principles’ Performance Expectations and the World Gold Council’s Responsible Gold Mining Principles.
The report continues to demonstrate Newmont’s commitment to transparency and accountability on its most material sustainability topics. To support the investment community in their understanding of the report, and to provide decision-useful information for stakeholders, Newmont will be hosting a webcast on July 8 to discuss the contents of its suite of sustainability reports. The full 2020 Sustainability Report, along with the ESG data tables and a comprehensive GRI/SASB content index, is available for download on Newmont’s website.
About Newmont
Newmont is the world’s leading gold company and a producer of copper, silver, zinc and lead. The Company’s world-class portfolio of assets, prospects and talent is anchored in favorable mining jurisdictions in North America, South America, Australia and Africa. Newmont is the only gold producer listed in the S&P 500 Index and is widely recognized for its principled environmental, social and governance practices. The Company is an industry leader in value creation, supported by robust safety standards, superior execution and technical expertise. Newmont was founded in 1921 and has been publicly traded since 1925.
At Newmont, our purpose is to create value and improve lives through sustainable and responsible mining. To learn more about Newmont’s sustainability strategy and initiatives, go to www.newmont.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210603005281/en/
Contact information
Media Contact
Courtney Boone, 303.837.5159
courtney.boone@newmont.com
Investor Contact
Eric Colby, 303.837.5724
eric.colby@newmont.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
